Efficacy and Safety of Beclomethasone Dipropionate in Patients 12 Years of Age and Older With Asthma
- Study Title
- Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
- Teva Identifier
- BDB-AS-30039 | 2015-002510-80
- ClinicalTrials.gov Identifier
- NCT02513160
- Study Status
- Completed
- Trial Condition(s)
- Persistent Asthma
- Interventions
- Drug: Beclomethasone Dipropionate 640 | Drug: Placebo | Drug: Beclomethasone dipropionate via 320 mcg BAI | Drug: albuterol/salbutamol | Drug: Beclomethasone dipropionate via 320 mcg MDI
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- September 30, 2015 - March 31, 2016
- Phase
- Phase 3
